pTEC22 Citations (3)
Originally described in: An in vivo platform for rapid high-throughput antitubercular drug discovery.Takaki K, Cosma CL, Troll MA, Ramakrishnan L Cell Rep. 2012 Jul 26;2(1):175-84. doi: 10.1016/j.celrep.2012.06.008. Epub 2012 Jul 20. PubMed Journal
Articles Citing pTEC22
| Articles |
|---|
| A Comparison of Red Fluorescent Proteins to Model DNA Vaccine Expression by Whole Animal In Vivo Imaging. Kinnear E, Caproni LJ, Tregoning JS. PLoS One. 2015 Jun 19;10(6):e0130375. doi: 10.1371/journal.pone.0130375. eCollection 2015. PubMed |
Optical Barcoding for Single-Clone Tracking to Study Tumor Heterogeneity.
Mohme M, Maire CL, Riecken K, Zapf S, Aranyossy T, Westphal M, Lamszus K, Fehse B.
Mol Ther. 2017 Jan 18. pii: S1525-0016(16)45496-1. doi: 10.1016/j.ymthe.2016.12.014.
PubMed
Associated Plasmids |
| The cyclic nitroxide antioxidant 4-methoxy-TEMPO decreases mycobacterial burden in vivo through host and bacterial targets. Black HD, Xu W, Hortle E, Robertson SI, Britton WJ, Kaur A, New EJ, Witting PK, Chami B, Oehlers SH. Free Radic Biol Med. 2019 May 1;135:157-166. doi: 10.1016/j.freeradbiomed.2019.03.010. Epub 2019 Mar 14. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.